OncoMatch/Clinical Trials/NCT07632664
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
Is NCT07632664 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies non-drug interventions for lung neoplasm.
This multicenter prospective clinical study focuses on elderly patients with lung cancer. We will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens, construct multidisciplinary perioperative comprehensive therapy, integrated Chinese-Western medicine full-cycle management and personalized postoperative rehabilitation systems, so as to form a whole-process optimized treatment model for elderly lung cancer.
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Disease stage
Required: Stage CLINICAL STAGE ELIGIBLE FOR CURATIVE SURGICAL RESECTION
Excluded: Stage DISTANT METASTASIS PREVENTING RADICAL RESECTION
clinical stage eligible for curative surgical resection
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07632664 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage CLINICAL STAGE ELIGIBLE FOR CURATIVE SURGICAL RESECTION is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify